Susquehanna Starts Cavium Networks (CAVM) at Positive
- Wall Street rallies as OPEC reaches output deal
- Pier 1 Imports (PIR) Reports In-Line Q2 EPS; Comps Fall 4.3%
- Intra-Cellular Therapies (ITCI) Announces ITI-007 Phase 3 Missed Primary Endpoint in Schizophrenia
- Vertex Pharma (VRTX) Announces FDA Approval for ORKAMBI in Children 6-11; Lowers 2016 ORKAMBI Revenue Outlook
- After-Hours Stock Movers 09/28: (AEGR) (PIR) (GSAT) Higher; (ITCI) (ATNM) (PRGS) Lower (more...)
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Susquehanna initiated coverage on Cavium Networks (NASDAQ: CAVM) with a Positive rating and a price target of $65.00.
Shares of Cavium Networks closed at $57.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Susquehanna Reiterates Positive Rating on NetApp (NTAP) Following Insight Conference
- Janney Montgomery Scott Starts Alnylam Pharmaceuticals (ALNY) at Neutral
- Janney Montgomery Scott Starts ProQR Therapeutics N.V. (PRQR) at Neutral
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesSusquehanna International Group of Companies
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!